Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NALTREXONE Cause Product dose omission issue? 359 Reports in FDA Database

Drink Less in 7 Days — Without Willpower

Clinically proven audio program. Just 25 min/day. Already helped 108,000+ people.

Start Today

According to the FDA Adverse Event Reporting System (FAERS), 359 reports of Product dose omission issue have been filed in association with NALTREXONE (NALTREXONE HYDROCHLORIDE). This represents 1.4% of all adverse event reports for NALTREXONE.

359
Reports of Product dose omission issue with NALTREXONE
1.4%
of all NALTREXONE reports
11
Deaths
28
Hospitalizations

How Dangerous Is Product dose omission issue From NALTREXONE?

Of the 359 reports, 11 (3.1%) resulted in death, 28 (7.8%) required hospitalization, and 1 (0.3%) were considered life-threatening.

Is Product dose omission issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NALTREXONE. However, 359 reports have been filed with the FAERS database.

What Other Side Effects Does NALTREXONE Cause?

Injection site reaction (4,360) Injection site pain (2,990) Alcoholism (1,928) Injection site mass (1,849) Nausea (1,782) Fatigue (1,486) Pain (1,348) Drug dependence (1,334) Drug ineffective (1,250) Feeling abnormal (1,241)

What Other Drugs Cause Product dose omission issue?

DUPILUMAB (18,189) USTEKINUMAB (9,405) GUSELKUMAB (9,267) LENALIDOMIDE (8,145) MEPOLIZUMAB (5,873) TOFACITINIB (5,646) VOXELOTOR (5,122) BELIMUMAB (4,671) SECUKINUMAB (4,572) APREMILAST (4,460)

Which NALTREXONE Alternatives Have Lower Product dose omission issue Risk?

NALTREXONE vs NAPHAZOLINE\PHENIRAMINE NALTREXONE vs NAPROXEN NALTREXONE vs NAPROXEN\NAPROXEN NALTREXONE vs NAPROXEN\PSEUDOEPHEDRINE NALTREXONE vs NAPROXEN\SUMATRIPTAN

Related Pages

NALTREXONE Full Profile All Product dose omission issue Reports All Drugs Causing Product dose omission issue NALTREXONE Demographics